BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 96 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $123,000 | +23.0% | 95,435 | -0.0% | 0.00% | – |
| Q3 2019 | $100,000 | -86.0% | 95,458 | -77.3% | 0.00% | – |
| Q2 2019 | $714,000 | -54.8% | 419,711 | -10.5% | 0.00% | – |
| Q1 2019 | $1,579,000 | +15.8% | 468,715 | +0.4% | 0.00% | – |
| Q4 2018 | $1,363,000 | -54.7% | 467,061 | -4.4% | 0.00% | -100.0% |
| Q3 2018 | $3,008,000 | -12.7% | 488,394 | +4.6% | 0.00% | 0.0% |
| Q2 2018 | $3,445,000 | +67.7% | 466,948 | +49.1% | 0.00% | 0.0% |
| Q1 2018 | $2,054,000 | -27.9% | 313,198 | -7.5% | 0.00% | 0.0% |
| Q4 2017 | $2,848,000 | -28.3% | 338,693 | -1.5% | 0.00% | 0.0% |
| Q3 2017 | $3,971,000 | -0.5% | 343,775 | +0.6% | 0.00% | 0.0% |
| Q2 2017 | $3,989,000 | +22.5% | 341,555 | +29.5% | 0.00% | 0.0% |
| Q1 2017 | $3,255,000 | -8.9% | 263,795 | +0.6% | 0.00% | 0.0% |
| Q4 2016 | $3,572,000 | -29.0% | 262,239 | +3.7% | 0.00% | -50.0% |
| Q3 2016 | $5,030,000 | +68.3% | 252,766 | +9.6% | 0.00% | +100.0% |
| Q2 2016 | $2,989,000 | +217.0% | 230,653 | +128.6% | 0.00% | – |
| Q1 2016 | $943,000 | -53.9% | 100,911 | +0.0% | 0.00% | -100.0% |
| Q4 2015 | $2,045,000 | +45.9% | 100,885 | +4.6% | 0.00% | – |
| Q3 2015 | $1,402,000 | -23.6% | 96,469 | +11.8% | 0.00% | -100.0% |
| Q2 2015 | $1,836,000 | +270.2% | 86,303 | +302.6% | 0.00% | – |
| Q1 2015 | $496,000 | – | 21,436 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|